jc1

JC168 是一种苯基类 peloruside 类似物和微管抑制剂，具备抗增殖和抗癌特性。通过促进微管蛋白聚合，JC168 影响微管的动态平衡，因此可用于研究微管相关疾病。

MJC13 是一种FKBP52靶向剂，具有抗肿瘤活性，可用于前列腺癌的研究。

JC124 是 NLRP3 炎症小体的抑制剂，具有神经保护和抗炎活性。

JC-171 is a selective NLRP3 inflammasome inhibitor, with an IC50 of 8.45 μM for inhibiting LPS ATP-induced interleukin-1β (IL-1β) release from J774A.1 macrophages[1]. JC-171 (0-100 μM) blocks NLRP3 inflammasome activation and IL-1β production in primary macrophages dose dependently[1]. Cell Viability Assay[1] Cell Line: J774A.1 murine macrophage cells JC-171 treatment delays the progression and reduces the severity of experimental autoimmune encephalomyelitis (EAE) in mouse[1]. Animal Model: Mice immunized subcutaneously with 200 μg Myelin oligodendrocyte glycoprotein (MOG) 35-55 peptide emulsified in Complete Freund's Adjuvant (CFA) on day 0 followed by injection of 200 ng of pertussis toxin. [1]. Chunqing Guo, et al. Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis. ACS Chem Neurosci. 2017 Oct 18;8(10):2194-2201.

JC-1 iodide 是一种有用的有机化合物，可用于生命科学领域的相关研究，其产品编号为 T65263。

SC 51316 is a nonpeptidic angiotensin II (AII) receptor antagonist.

Sjc 13 is an azaindolidine derivative that is a cell adhesion molecule inhibitor.

CJC-1295 acetate(863288-34-0 free base) (DAC:GRF acetate) 是生长激素释放激素 (GHRH)（也称为生长激素释放因子 (GRF)）和生长激素促分泌素 (GHS) 的合成类似物。